JUPITER: major implications for vascular risk assessment.
This Editorial comments on the recently published JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin), the further evidence it provides for supporting the role of statins in primary prevention and the major implications this may hold for vascular risk assessment and clinical practice guidelines.
Tziomalos
Konstantinos
K
Athyros
Vasilios G
VG
Karagiannis
Asterios
A
Mikhailidis
Dimitri P
DP
D002097:C-Reactive Protein / Q000032:analysis; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011322:Primary Prevention; D018570:Risk Assessment; D014652:Vascular Diseases / Q000453:epidemiology / Q000517:prevention & control*
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D002097:C-Reactive Protein